                         SEQUENCE LISTING

<110>  LI, ZIHAI
       LIU, BEI
       WU, SHUANG
 
<120>  HSP90 INHIBITOR FOR THE TREATMENT OF CANCER AND INFLAMMATORY 
       DISEASES

<130>  MESC.P0060WO

<140>  Unknown
<141>  2013-03-04

<150>  61/606,551
<151>  2012-03-05

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Leu Asn Ile Ser Arg Glu Met Leu Gln Gln Ser Lys Ile Leu Lys Val 
1               5                   10                  15      


Ile Arg Lys Asn Ile Val Lys Lys Cys Leu Glu Leu Phe Ser Glu Leu 
            20                  25                  30          


Ala Glu Asp Lys Glu 
        35          


<210>  2
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Leu Asn Val Ser Arg Glu Thr Leu Gln Gln His Lys Leu Leu Lys Val 
1               5                   10                  15      


Ile Arg Lys Lys Leu Val Arg Lys Thr Leu Asp Met Ile Lys Lys Ile 
            20                  25                  30          


Ala Asp Asp Lys Tyr 
        35          


<210>  3
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln Leu Asn Ile Ser 
1               5                   10                  15      


Arg Glu Met Leu Gln Gln Ser Lys Ile Leu Lys Val Ile Arg Lys Asn 
            20                  25                  30          


Ile Val Lys Lys Cys Leu Glu Leu Phe Ser Glu Leu Ala Glu Asp Lys 
        35                  40                  45              


Glu 
    


<210>  4
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln Leu Asn Val Ser 
1               5                   10                  15      


Arg Glu Thr Leu Gln Gln His Lys Leu Leu Lys Val Ile Arg Lys Lys 
            20                  25                  30          


Leu Val Arg Lys Thr Leu Asp Met Ile Lys Lys Ile Ala Asp Asp Lys 
        35                  40                  45              


Tyr 
    


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Arg Met Arg Arg Met Arg Arg Met Arg Arg 
1               5                   10  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210>  7
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Phe Leu Arg Glu Leu Ile Ser Asn Ala Ser Asp Ala Leu Asp Lys Ile 
1               5                   10                  15      


Arg Leu Ile Ser Leu Thr Asp Glu Asn Ala Leu Ser Gly Asn Glu Glu 
            20                  25                  30          


Leu Thr Val Lys Ile Lys 
        35              


<210>  8
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Leu Asn Val Ser Arg Glu Thr Leu Gln Gln His Lys Leu Leu Lys Val 
1               5                   10                  15      


Ile Arg Lys Lys Leu Pro Pro Lys Thr Leu Asp Met Ile Lys Lys Ile 
            20                  25                  30          


Ala Asp Asp Lys Tyr 
        35          


<210>  9
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Leu Asn Ile Ser Arg Glu Met Leu Gln Gln Ser Lys Ile Leu Lys Val 
1               5                   10                  15      


Ile Arg Lys Asn Ile Val Lys Lys Cys Leu Glu Leu Phe Ser Glu Leu 
            20                  25                  30          


Ala Glu Asp Lys Glu Asn 
        35              


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 
1               5                   10                  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala 
1               5                   10                  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Lys Ala Ala Lys Lys Ala Ala Lys Ala Ala Lys Lys Ala Ala 
1               5                   10                  


<210>  13
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Lys Leu Gly Lys Lys Leu Gly Lys Leu Gly Lys Lys Leu Gly Lys Leu 
1               5                   10                  15      


Gly Lys Lys Leu Gly 
            20      


